![]() | Up a level |
Kanavos, Panos ORCID: 0000-0001-9518-3089, Visintin, Erica and Angelis, Aris
ORCID: 0000-0002-0261-4634
(2024)
Use of the ESMO-magnitude of clinical benefit scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis.
The Lancet Oncology, 25 (12).
1644 - 1654.
ISSN 1470-2045
Angelis, Aris ORCID: 0000-0002-0261-4634, Aggarwal, Ajay, Miners, Alec, Cairns, John and Briggs, Andrew
(2023)
The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?
Journal of the Royal Society of Medicine, 116 (10).
324 - 330.
ISSN 0141-0768
Angelis, Aris ORCID: 0000-0002-0261-4634, Harker, Martin, Cairns, John, Seo, Mikyung Kelly, Legood, Rosa, Miners, Alec, Wiseman, Virginia, Chalkidou, Kalipso, Grieve, Richard and Briggs, Andrew
(2023)
The evolving nature of Health Technology Assessment: a critical appraisal of NICE’s new methods manual.
Value in Health, 26 (10).
1503 - 1509.
ISSN 1098-3015
Angelis, Aris ORCID: 0000-0002-0261-4634, Montibeller, Gilberto Neto and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2023)
A structured methodology for essential medicines lists and health emergency stockpiles: experience with the Emergency Medicines Buffer Stock in the United Kingdom.
Social Science and Medicine, 337.
ISSN 0277-9536
Angelis, Aris ORCID: 0000-0002-0261-4634, Polyakov, Roman, Wouters, Olivier J.
ORCID: 0000-0002-2514-476X, Torreele, Els and McKee, Martin
(2023)
High drug prices are not justified by industry’s spending on research and development.
BMJ, 380 (8371).
ISSN 1756-1833
Angelis, Aris ORCID: 0000-0002-0261-4634, Suarez Alonso, Carlos, Kyriopoulos, Ilias
ORCID: 0000-0002-3932-8228 and Mossialos, Elias
ORCID: 0000-0001-8664-9297
(2022)
Funding sources of therapeutic and vaccine clinical trials for COVID-19 vs non-COVID-19 indications, 2020-2021.
JAMA network open, 5 (8).
ISSN 2574-3805
Angelis, Aris ORCID: 0000-0002-0261-4634 and Phillips, Lawrence D.
(2021)
Advancing structured decision-making in drug regulation at the FDA and EMA.
British Journal of Clinical Pharmacology, 87 (2).
395 - 405.
ISSN 0306-5251
Angelis, Aris ORCID: 0000-0002-0261-4634, Baltussen, Rob and Tervonen, Tommi
(2021)
The need for novel approaches in assessing the value of COVID-19 vaccines.
American Journal of Public Health, 111 (2).
205 - 208.
ISSN 0090-0036
Angelis, Aris ORCID: 0000-0002-0261-4634, Naci, Huseyin
ORCID: 0000-0002-7192-5751 and Hackshaw, Allan
(2020)
Recalibrating health technology assessment methods for cell and gene therapies.
PharmacoEconomics, 38 (12).
pp. 1297-1308.
ISSN 1170-7690
Angelis, Aris ORCID: 0000-0002-0261-4634, Thursz, Mark, Ratziu, Vlad, O'Brien, Alistair, Serfaty, Lawrence, Canbay, Ali, Schiefke, Ingolf, Bana e Costa, João C., Lecomte, Pascal and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2020)
Early health technology assessment during nonalcoholic steatohepatitis drug development: a two-round, cross-country, multicriteria decision analysis.
Medical Decision Making, 40 (6).
830 - 845.
ISSN 0272-989X
Angelis, Aris ORCID: 0000-0002-0261-4634, Kanavos, Panos
ORCID: 0000-0001-9518-3089 and Phillips, Lawrence D.
(2020)
ICER value framework 2020 update: recommendations on the aggregation of benefits and contextual considerations.
Value in Health, 23 (8).
1040 - 1048.
ISSN 1098-3015
Angelis, Aris ORCID: 0000-0002-0261-4634, Linch, Mark, Montibeller, Gilberto, Molina Lopez, Maria Teresa, Zawada, Anna, Orzel, Kinga, Arickx, Francis, Espin, Jaime and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2020)
Multiple criteria decision analysis for HTA across four EU member states: piloting the Advance Value Framework.
Social Science & Medicine, 246.
ISSN 0277-9536
Tervonen, Tommi, Angelis, Aris ORCID: 0000-0002-0261-4634, Hockley, Kimberley, Pignatti, Francesco and Phillips, Lawrence D.
(2019)
Quantifying preference in drug benefit-risk decisions.
Clinical Pharmacology and Therapeutics, 106 (5).
pp. 955-959.
ISSN 0009-9236
Kanavos, Panos ORCID: 0000-0001-9518-3089, Angelis, Aris
ORCID: 0000-0002-0261-4634 and Drummond, Michael
(2019)
An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed?
European Journal of Health Economics, 20 (3).
pp. 329-332.
ISSN 1618-7598
Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2018)
Comment on: “Does MCDA trump CEA?”.
Applied Health Economics and Health Policy.
ISSN 1175-5652
Angelis, Aris ORCID: 0000-0002-0261-4634
(2018)
Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden.
Medical Decision Making: Policy and Practice, 3 (2).
ISSN 2381-4683
Angelis, Aris ORCID: 0000-0002-0261-4634, Lange, Ansgar and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2018)
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.
European Journal of Health Economics, 19 (1).
pp. 123-152.
ISSN 1618-7598
Angelis, Aris ORCID: 0000-0002-0261-4634, Montibeller, Gilberto, Hochhauser, Daniel and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2017)
Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
BMC Medical Informatics and Decision Making, 17 (149).
ISSN 1472-6947
Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2017)
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework.
Social Science & Medicine, 188.
pp. 137-156.
ISSN 0277-9536
Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Pringle, Edward and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2017)
Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature.
Retina, 37 (5).
pp. 886-895.
ISSN 1539-2864
Angelis, Aris ORCID: 0000-0002-0261-4634, Tordrup, David and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2017)
Is the funding of public national health systems sustainable over the long term? Evidence from eight OECD countries.
Global Policy, 8 (S2).
pp. 7-22.
ISSN 1758-5880
Angelis, Aris ORCID: 0000-0002-0261-4634, Kanavos, Panos
ORCID: 0000-0001-9518-3089 and Montibeller, Gilberto
(2017)
Resource allocation and priority setting in health care: a multi-criteria decision analysis problem of value?
Global Policy, 8 (S2).
pp. 76-83.
ISSN 1758-5880
Nicod, Elena, Jackson, Timothy L., Grimaccia, Federico, Angelis, Aris ORCID: 0000-0002-0261-4634, Costen, Marc, Haynes, Richard, Hughes, Edward, Pringle, Edward, Zambarakji, Hadi and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2016)
Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach.
European Journal of Health Economics, 17 (8).
pp. 991-999.
ISSN 1618-7598
Angelis, Aris ORCID: 0000-0002-0261-4634
(2016)
Why are the prices of new medicines so high and what can we do about it? (F8).
European Health Forum Gastein
(30 Sep 2016).
Website.
Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2016)
Critique of the American Society of Clinical Oncology value assessment framework for cancer treatments: putting methodologic robustness first.
Journal of Clinical Oncology, 34 (24).
pp. 2935-2936.
ISSN 0732-183X
Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2016)
Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment.
PharmacoEconomics, 34 (5).
pp. 435-446.
ISSN 1170-7690
Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2015)
Large scale mergers and acquisitions in the pharmaceutical industry: 1 + 1 = 1?
Health and Social Care Blog
(12 Nov 2015).
Website.
Angelis, Aris ORCID: 0000-0002-0261-4634, Tordrup, David and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2015)
Socio-economic burden of rare diseases: a systematic review of cost of illness evidence.
Health Policy, 119 (7).
pp. 964-979.
ISSN 0168-8510
Tervonen, Tommi, Naci, Huseyin ORCID: 0000-0002-7192-5751, van Valkenhoef, Gert, Ades, Anthony E., Angelis, Aris
ORCID: 0000-0002-0261-4634, Hillege, Hans L. and Postmus, Douwe
(2015)
Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention.
Medical Decision Making, 35 (7).
pp. 859-871.
ISSN 0272-989X
Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris
ORCID: 0000-0002-0261-4634
(2014)
Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1?
Pharmaceutical Medicine, online.
ISSN 1178-2595
Tordrup, David, Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2013)
Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey.
Applied Health Economics and Health Policy, 11 (6).
pp. 639-652.
ISSN 1175-5652
Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Prevost, Andrew T., Simpson, Andrew R.H. and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2013)
Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy.
Retina, 33 (10).
pp. 2012-2017.
ISSN 0275-004X
Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Prevost, Toby, Simpson, Andrew and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2013)
Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion.
Retina, 33 (6).
pp. 1099-1108.
ISSN 1539-2864
Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris
ORCID: 0000-0002-0261-4634
(2013)
Multiple criteria decision analysis for valuebased assessment of new medical technologies:a conceptual framework.
LSE Health working papers (33).
LSE Health, London, UK.
Jackson, Timothy, Nicod, Elena, Simpson, Andrew, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2013)
Symptomatic vitreomacular adhesion.
Retina, 33 (8).
pp. 1503-1511.
ISSN 1539-2864